Third-line therapy for overactive bladder in the elderly: Nuances and considerations.

Jacqueline ZilliouxEmily A SlopnickSandip P Vasavada

Published in: Neurourology and urodynamics (2022)

Advanced age and frailty should not preclude third-line therapy for refractory OAB, as available data support their efficacy and safety in these populations. Ultimately, treatment choices should be individualized and involve shared decision-making.

Keyphrases

community dwelling
electronic health record
middle aged
big data
machine learning
combination therapy